TUNICRIS-julkaisut - Trepo

Viitteet 1-1 / 1

Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo : Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial

Pothuri, Bhavana; Han, Sileny; Chase, Dana M.; Heitz, Florian; Burger, Robert A.; Gaba, Lydia; Van Le, Linda; Guerra, Eva; Bender, David; Korach, Jacob; Cloven, Noelle; Churruca, Cristina; Follana, Philippe; DiSilvestro, Paul; Baurain, Jean François; Jardon, Kris; Pisano, Carmela; Peen, Ulla; Mäenpää, Johanna; Gupta, Divya; Bacqué, Emeline; Li, Yong; Compton, Natalie; Antonova, Jenya; Monk, Bradley J.; González-Martín, Antonio (2024)
article

Objective: To assess patient-reported health-related quality of life (HRQoL) in patients with ovarian cancer (OC) who received niraparib as first-line maintenance therapy. Methods: PRIMA/ENGOT-OV26/GOG-3012 (NCT02655016) ...